Boston Scientific Corp (BSX)

05:02 AM

Boston Scientific’s SVP Brown Vance sells shares for $458,904 - Investing.com

05:02 AM

04:48 AM

Boston Scientific’s SVP Brown Vance sells shares for $458,904 By Investing.com - Investing.com India

04:48 AM

01:57 AM

Boston Scientific (BSX) Q1 Earnings Preview: Consistent Outperformance Expected - GuruFocus

01:57 AM

11:11 AM

Boston Scientific Presses Its Advantage in Pulsed Field Ablation - Morningstar

11:11 AM

08:43 AM

What To Expect From Boston Scientific’s (BSX) Q1 Earnings - Barchart.com

08:43 AM

Apr 21, 2025

TD Cowen maintains Boston Scientific stock with $115 target - Investing.com

Apr 21, 2025

Apr 21, 2025

Bearish Options Trading Surges for Boston Scientific (BSX) | BSX Stock News - GuruFocus

Apr 21, 2025

Apr 21, 2025

Those who invested in Boston Scientific (NYSE:BSX) five years ago are up 157% - Yahoo Finance

Apr 21, 2025

Apr 20, 2025

Boston Scientific’s Strong Growth Prospects and Resilience Drive Buy Rating - TipRanks

Apr 20, 2025

Apr 19, 2025

Is Boston Scientific Corporation (BSX) the Best Low Volatility Stock to Buy Now? - Insider Monkey

Apr 19, 2025

Apr 17, 2025

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Boston Scientific gets analyst upgrade on Farapulse PFA strength - MassDevice

Apr 17, 2025

Apr 17, 2025

Should You Buy Boston Scientific Stock Ahead Of Q1 Earnings? - Barchart.com

Apr 17, 2025

Apr 17, 2025

Should You Buy Boston Scientific Stock Ahead of Q1 Earnings? - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Infusion Pumps Market to Soar at a CAGR of ~10% by 2032, Owing to the Advancements in Technology and Increased Demand in Healthcare | DelveInsight - GlobeNewswire Inc.

Apr 17, 2025

Apr 17, 2025

Boston Scientific Corporation (BSX): Among the Innovative Healthcare Stocks to Watch in 2025 - Insider Monkey

Apr 17, 2025

Apr 17, 2025

Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Boston Scientific (NYSE:BSX) Ticks All The Boxes When It Comes To Earnings Growth - Yahoo Finance

Apr 17, 2025

Apr 17, 2025

Needham Upgrades Boston Scientific (WBAG:BSXC) - Nasdaq

Apr 17, 2025

Apr 16, 2025

Needham upgrades Boston Scientific on easing competition, growth opportunities - Baystreet.ca

Apr 16, 2025

Apr 16, 2025

This Boston Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Apr 16, 2025

Apr 16, 2025

A Glimpse Into The Expert Outlook On Boston Scientific Through 13 Analysts - Benzinga

Apr 16, 2025

Apr 16, 2025

Needham raises Boston Scientific stock to Buy, target at $113 - Investing.com

Apr 16, 2025

Apr 15, 2025

Boston Scientific Corporation (BSX): A Bull Case Theory - Yahoo Finance

Apr 15, 2025

Apr 15, 2025

RBC Capital maintains Outperform on Boston Scientific, $116 target - Investing.com

Apr 15, 2025

Apr 15, 2025

Smart Pills Market Detailed In New Research Report 2025 | Boston - openPR.com

Apr 15, 2025

Apr 13, 2025

A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX) - Yahoo Finance

Apr 13, 2025

Apr 12, 2025

Truist Lowers Price Target for Boston Scientific (BSX) Ahead of Q1 Results | BSX Stock News - GuruFocus

Apr 12, 2025

Apr 11, 2025

Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note - Yahoo Finance

Apr 11, 2025

Apr 11, 2025

Boston Scientific Corp. stock rises Friday, still underperforms market - MarketWatch

Apr 11, 2025

Apr 11, 2025

Boston Scientific price target lowered to $113 from $120 at Truist - TipRanks

Apr 11, 2025

Apr 10, 2025

Is Boston Scientific Gaining or Losing Market Support? - Benzinga

Apr 10, 2025

Apr 10, 2025

Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True? - Yahoo Finance

Apr 10, 2025

Apr 10, 2025

Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo

Apr 10, 2025

Apr 09, 2025

FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave - BioWorld MedTech

Apr 09, 2025

Apr 09, 2025

Lobbying Update: $20,000 of BOSTON SCIENTIFIC CORPORATION lobbying was just disclosed - Nasdaq

Apr 09, 2025

Apr 09, 2025

What to Expect From Boston Scientific’s Q1 2025 Earnings Report - Nasdaq

Apr 09, 2025

Apr 09, 2025

Boston Scientific (NYSE:BSX) Announces Robust Q4 Results With Increased Sales And Net Income - Yahoo Finance

Apr 09, 2025

Apr 09, 2025

Interventional Neurology Market Deep Research 2025-2032 | - openPR.com

Apr 09, 2025

Apr 09, 2025

What To Expect From Boston Scientific’s Q1 2025 Earnings Report - Barchart.com

Apr 09, 2025

Apr 07, 2025

PFA non-inferior, even superior, to cryoablation for paroxysmal AF - BioWorld MedTech

Apr 07, 2025

Apr 07, 2025

Boston Scientific Insiders Sell US$1.8m Of Stock, Possibly Signalling Caution - Yahoo Finance

Apr 07, 2025

Apr 04, 2025

Health Rounds: Some early breast cancers may not need surgery after chemo - MarketScreener

Apr 04, 2025

Apr 03, 2025

Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Tariffs on medical devices could raise healthcare costs - The Business Journals

Apr 03, 2025

Apr 03, 2025

Boston Scientific Sued Over Endoscopic Medical Device Patent - Bloomberg Law News

Apr 03, 2025

Apr 03, 2025

Boston Scientific (BSX) Faces Pressure from New Tariffs - GuruFocus

Apr 03, 2025

Apr 03, 2025

Stryker, Boston Scientific down as new tariffs impact medtech industry - Seeking Alpha

Apr 03, 2025

Apr 03, 2025

Price Over Earnings Overview: Boston Scientific - Benzinga

Apr 03, 2025

Apr 03, 2025

Here's Why Boston Scientific (BSX) is a Strong Growth Stock - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - Yahoo Finance

Apr 03, 2025

Apr 03, 2025

Boston Scientific CEO Michael Mahoney sells $16.4 million in stock By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 02, 2025

No benefit found for cerebral protection device in TAVR - BioWorld MedTech

Apr 02, 2025

Apr 02, 2025

Boston Scientific CEO Michael Mahoney sells $16.4 million in stock - Investing.com India

Apr 02, 2025

Apr 02, 2025

Boston Scientific closes Bolt Medical acquisition - MassDevice

Apr 02, 2025